Full Report

Claude View

Know the Business

Carysil is a German-technology quartz-sink manufacturer dressed up as an Indian consumer durable — roughly 80% of revenue leaves the country, and the single most important commercial relationship is being the sole quartz supplier to Karran USA (~150k units a year), with IKEA and GROHE tied in behind it. The economic engine is a capital-intensive contract-manufacturing business with a retail brand bolted on top: quartz sink capacity of 1 million units globally with cost leadership from a concentrated Bhavnagar plant drives most of the gross margin, while the India branded business (~21% of revenue, 4,000+ dealers) is the optionality on premiumisation. The market is likely overestimating the durability of the 17–19% EBITDA margin (working capital has bloated to 251 days and US tariff exposure is real) and underestimating how much operating leverage is left if quartz utilisation climbs from 65% to 80%+.

How This Business Actually Works

Carysil sells physical product that has to be moulded, fired, shipped across oceans and sold through someone else's retail shelf — and it does this at a margin that depends almost entirely on three variables: the utilisation of the quartz plant, the freight/INR cost stack, and the mix between OEM export and branded India revenue.

The profit machinery runs like this. Carysil manufactures composite quartz sinks in India using proprietary German technology (originally sourced from Schock), at a labour-adjusted cost that European incumbents cannot match. It then ships those sinks to three kinds of customers: large Western OEMs and retailers (Karran, IKEA, GROHE, a top-three UK kitchen brand), which take capacity but squeeze margin; its own UK and US subsidiaries (Carysil Products UK, United Granite LLC, Sternhagen), which capture more margin but carry inventory and people cost; and the Indian dealer network of 4,000+ outlets where the branded play earns premium-segment margins but is still sub-scale at ₹170 Cr of the ₹815 Cr total.

Incremental profit comes from two narrow places. First, marginal quartz sinks above roughly 70% utilisation — the fixed cost of the plant is already paid, so the next 200k units drop close to 40% contribution to EBITDA. Second, converting India from distribution to brand; management has set ₹500 Cr as the medium-term domestic target (roughly 3x current), and those are high-margin sales. Everything else — tiles, surfaces, faucets, appliances — is either small or still running below breakeven in the case of the US Granite subsidiary (which turned EBITDA-positive only in FY25).

The structural problem is that gross margin is squeezed from both ends: raw material (resin, quartz granules) moves with oil and global commodity cycles, and ocean freight on high-volume low-density sinks is a recurring tax on the P&L. The Red Sea disruption in FY24–25 is visible in the 500bps margin compression from FY22's peak.

The Playing Field

Carysil is the smallest of the six real kitchen-and-bath peers by market cap, but it runs a fundamentally different business than any of them — the closest functional comparable is probably a Chinese or Turkish quartz sink exporter, not an Indian listed ceramic or appliance company.

Two things jump out of this set. First, Carysil is the only peer posting double-digit revenue growth at a respectable ROCE — Kajaria and Cera are compounders but have stalled near 5–7% growth, and Hindware is losing money. Second, the ROCE gap to Cera (22%) exposes Carysil's real weakness: it is more capital-intensive per rupee of sale (large moulds, global inventory-in-transit, UK/US warehousing) than a pure domestic ceramic branded play. Stove Kraft's 32% ROCE is flattered by a high-working-capital-turnover asset-light appliance model; it should not be read as directly comparable economics.

What "good" looks like in this industry is Cera's combination — 22% ROCE on a premium branded domestic mix with modest exports. Carysil's bet is that it can keep Cera-like margins while adding a global export moat on top. The peer data says that hasn't been proven yet, because ROCE has trended down from 27% in FY22 to 15% in FY25 while Cera and Kajaria held steady.

Is This Business Cyclical?

Yes, but not the way people think — the cycle that matters is not Indian real estate, it is the US housing-renovation cycle layered on top of global ocean freight and INR/USD.

FY21–FY22 was the peak: US home-renovation demand after COVID pulled quartz sink volumes to record levels, ocean freight was still priced normally, and operating margin hit 22% with ROCE of 27%. The unwind since then is a textbook three-factor cyclical compression — Red Sea disruption on shipping (FY24), raw-material inflation (FY23), and the European consumer slowdown (FY24–25). The tell is working capital: inventory days jumped from 184 in FY23 to 290 in FY25 because the company is holding more finished goods to buffer against shipping disruption and slower retailer pull-through. The 251-day cash conversion cycle is now almost double the FY22 level.

The business will also take a discrete hit from any structural US tariff on Indian imports — roughly 21% of revenue runs through the US, and the Karran relationship is a single point of concentration. The upside cycle case — US housing-renovation reacceleration plus IKEA global RFQ win ramping — is equally real but further out.

The Metrics That Actually Matter

Forget the headline numbers. The five that drive value creation or destruction here are all operational.

Quartz sink capacity utilisation is the single cleanest operating lever — management guidance implies 80% next year, and each 5-point move is directly visible in gross margin because the plant is mostly fixed cost. The India revenue share is the structural margin story: the company is running ₹170 Cr of domestic branded sales through a 4,000-dealer network built over a decade, and any acceleration toward the ₹500 Cr target re-rates the business from "mid-teen-margin exporter" to "premium consumer durable." Inventory days is the honest signal — if it normalises back toward 180, ROCE recovers automatically without any volume lift; if it stays at 290, the company is silently funding the cycle with the balance sheet.

Customer concentration is the under-reported risk. Karran USA is the sole-source relationship for quartz sink supply and accounts for roughly 150,000 units a year — meaningful against total quartz volumes of 645,000. Losing or even renegotiating Karran would hit both revenue and plant utilisation in the same quarter.

What I'd Tell a Young Analyst

The Carysil thesis lives or dies on three things that are all knowable before they show up in the quarterly. First, track the quartz utilisation number management reports every quarter — it has already moved from 65% to 75% in Q1FY26, and the next two prints will either confirm operating leverage or expose demand weakness. Second, watch the India segment growth in isolation; the investor deck breaks it out and it is running above 17% YoY, but the ₹500 Cr target is a 5-year ask and the domestic channel-build is still more narrative than execution. Third, read every Karran and IKEA data point — any RFQ loss, tariff news, or pricing renegotiation is a first-order event, not a footnote.

The market is probably overestimating the stability of FY25 margins (freight is a recurring hostage, the US tariff risk is live) and underestimating two things: the optionality from IKEA's global non-US RFQ ramp at full investment (₹20 Cr of new moulds committed specifically for IKEA), and the inventory unwind that would follow any normalisation of Red Sea routing. If you see inventory days drop from 290 back toward 200 without a revenue decline, you have a clean 300–400bps ROCE recovery priced into the stock.

What would genuinely change the thesis: a Karran contract renegotiation or loss, a structural US import tariff on Indian home goods, or a second full year of inventory days above 280. On the other side, a domestic revenue inflection through ₹250 Cr or an IKEA-scale OEM win confirmed at contract level would justify a re-rating toward Cera-like multiples.

Claude View

The Numbers

Carysil trades at ~29x trailing earnings and ~198x FY25 free cash flow because the market is pricing the FY26 margin recovery, not the FY25 capital inefficiency. The single metric most likely to rerate or derate the stock is free cash flow conversion — reported profit was ₹64 Cr in FY25 but FCF was only ₹13 Cr, the rest vanished into a working-capital build that is either temporary inventory positioning for the tariff whiplash or structural capital trapping. Q4 FY26 will tell us which.

Valuation snapshot

The stock has doubled off the ₹582 tariff-scare low and sits ~15% off the ₹1,072 post-tariff-cut high. MNCL carries BUY, target ₹1,190 (FY28E rollover). On FY25 reported earnings the stock is 40x; only the 9M FY26 NI surge (₹71 Cr, already above full-year FY25's ₹64 Cr) drags the multiple back to the mid-twenties.

Revenue and earnings power — the 11-year arc

Revenue compounded at 20.5% CAGR over 11 years, net income at ~23% — but net income has flatlined at ₹53–65 Cr since FY22 even as revenue doubled. A classic capex-cycle compression: depreciation and interest walked up in lockstep with the asset base, eating every rupee of operating leverage.

Margin story — the resin, not the volume

Op margin compressed ~500 bps from FY22's 22% to FY25's 17%. The FY26 bounce to 19% is real but single-source — cheaper imported quartz resin, not volume leverage. Net margin is still 300+ bps below the FY22 peak because interest and depreciation on the capex debt have roughly doubled. For a multiple re-rating, margin expansion must move from cost-pull (resin) to volume-pull (utilisation 65% → 80%).

Quarterly trajectory — recovery is visible

Q3 FY25 was the earnings trough (₹13 Cr / 14% margin) — the US tariff scare at its worst. Three quarters later, margins hold a tight 19% band and net income has roughly doubled. 9M FY26 (₹691 Cr / ₹71 Cr NI) already beats full-year FY25 — hence the 52% six-month rally.

Cash generation — the inconvenient truth

Capital efficiency — Warren's question answered

Warren asked: genuine expansion or gold-plating? Genuine capacity — quartz sink line, steel sink ramp, solar — but priced as though the payback has already been earned. It has not. Asset turn on new capex is 1.2x vs Cera's asset-light ~3x. Until quartz utilisation moves 65% → 80%, Carysil runs Cera's balance-sheet intensity with Hindware's earnings volatility.

Balance sheet and leverage — still fine, but tighter

FY25 looks healthier than FY24 only because of a ₹168 Cr reserves injection (equity capital ₹5→₹6 Cr = ~5% share count expansion, almost certainly a QIP). That explains the promoter stake trim from 44% to 41.3% Warren flagged — dilution from a fresh issue, not a creeping sale. D/E at 0.42x is manageable; interest coverage 11x is comfortable.

Working capital — the hidden leverage

Inventory days blew out from 184 (FY23) to 290 (FY25) — roughly ₹250 Cr of working capital locked in finished sinks. Management says this is tariff-era staging plus new-plant stocking. If true, Q4 FY26 inventory days should revert toward 200; every 30 days released is ~₹70 Cr of cash back to ROCE. If false, write-down risk on stale SKUs.

Peer comparison — where Carysil actually sits

Cera is the anchor: 22% ROCE at 28x P/E. Carysil at 15% ROCE trades at essentially the same multiple — the market is paying Cera multiples for 30% lower ROCE, betting on mean reversion as utilisation climbs. Carysil needs ROCE ≥ 20% by FY27 to hold this valuation; if ROCE stays 15–17%, the stock derates to 20x ≈ ₹640.

Free-cash-flow adjusted valuation

Warren's FCF-adjusted valuation question. 198x P/FCF on reported FY25 is noise — FCF was working-capital suppressed. On 3-year avg FCF (~₹50 Cr) the multiple is ~52x, still 50–70% above Cera/Kajaria. EV/EBITDA at 14x is the one metric where Carysil looks cheap — it normalises the capex cycle and is how institutional buyers anchor the position.

Stress test — Warren's bear case quantified

Scenario construction (answering Warren Q3):

Bear (USA flat at tariff-era low, UK 0% growth): India grows 25% p.a., RoW 15% p.a., USA recovers only to 50% of FY25. Margin holds at 17%. FY27 EPS ≈ ₹33 — stock at ₹906 is a 27x multiple, not cheap in a bear outcome.

Base (UK flat, USA gradual recovery, India on plan): Revenue hits management's ₹1,200 Cr aspiration. Op margin ~19% as utilisation improves. FY27 EPS ≈ ₹46 — current price is a 20x multiple on FY27, reasonable for the asset.

Bull (volume leverage returns, 80%+ utilisation, India at ₹300 Cr+): FY27 EPS ≈ ₹60, stock re-rates to 25–28x = ₹1,500–₹1,680, upside ~65–85%.

The base case supports today's price; the upside is conditional on India executing; the downside is real if UK stays flat and tariff recovery stalls.

Ownership — the promoter dilution

Promoter stake dropped ~250 bps in Sep-24 as DII jumped 7% → 11%. Combined with the ₹168 Cr reserves bump, this was a QIP/preferential issue — not an on-market promoter sale. DII now ~12%, FII 1.6%; retail shareholder count fell 65k → 48k. Holder quality is improving.

The one metric watchlist

Closing view

What the numbers confirm: The FY26 margin recovery is real and printed three consecutive quarters in a row. Debt has come down, the balance sheet was recapitalised, institutional ownership is improving. At 14x TTM EV/EBITDA, this is not the most expensive way to own the Indian kitchen durables theme.

What the numbers contradict: The "brand transition / India pivot / compounder" narrative is not yet in the reported financials. ROCE has halved from the FY22 peak, FCF conversion is the weakest in the peer set, and ₹611 Cr of cumulative capex has produced ₹540 Cr of incremental revenue and essentially no incremental net income. On any fundamentals-based screen, this is a mid-cycle export manufacturer with capex overhang, not a compounder.

What must be watched next quarter: Q4 FY26 (May-26 release). Three gates: (1) Op margin ≥ 19% (tests margin durability); (2) Inventory days ≤ 250 (tests working-capital narrative); (3) 9M FY26 commentary on quartz-sink utilisation trajectory toward 80%. Miss any two of three and the stock de-rates to the ₹650–₹750 zone.

Claude View

People & Governance

Grade: B. A three-decade, promoter-led exporter with genuine skin-in-the-game (MD holds ~30% direct, promoter group 41.34%, zero pledge) and a credentialed 75%-independent board — but with thin bench depth (two executive directors total), a FY25 NSE/BSE monetary penalty for an NRC composition lapse, a Rs. 7.89 Cr MD pay-package on standalone PAT of ~Rs. 56 Cr, and a multi-year pattern of Chirag Parekh over-promising the "Rs. 1,000 Cr FY25" revenue target that the company ultimately missed.

The People Running This Company

Carysil is structurally a one-principal company. Chirag Parekh has been on the board since November 2002 and chairs or sits on every board committee. The only other executive on the board is the CFO (appointed ED in February 2024). The board otherwise is six independent directors, all appointed in the last ~10 years — three of them within the last 24 months, giving the refresh an unusually new feel for a 38-year-old promoter company.

What matters here: The combination of (a) the MD holding a meaningful personal stake but (b) no other director holding any equity at all is classic promoter-led India. Independent directors are formally independent (SEBI checks pass), but they have no alignment through ownership — only sitting fees of Rs. 5.7 to 7.0 lakhs a year. Dr. Sonal Ambani's term expires March 31, 2026 after two 5-year terms; her replacement will be an early test of whether the board becomes more or less independent.

What They Get Paid

The promoter MD takes a large absolute package relative to the company's profit pool. Shareholders had to approve payment "in excess of threshold limits" as a special resolution (FY23 AGM) — this is the LODR Schedule V trigger, meaning MD compensation exceeded 5% of standalone net profit.

The commission component is formula-linked (Rs. 86.3 L on FY25 profit), so pay scales with results — the right structural design. But the base+perks block (Rs. 7.03 Cr fixed) is high for a company whose PAT has compounded in the low single-digits over FY24-FY25 despite the revenue narrative. The CFO's compensation was revised upward via postal ballot in March 2025; approval rate was 99.76%, reflecting the minority shareholders' effective powerlessness given the ~41% promoter block.

Are They Aligned?

Ownership and control

The promoter stake has drifted from 44.04% (FY22) to 41.34% (current) — about a 270 bps decline. The step-down in Q2 FY25 (from 43.8% to 41.37%) coincided with the Rs. 125 Cr QIP in July 2024, which diluted the promoter. Importantly, no sales by the promoter themselves — the decline is 100% dilution from fresh issue, not an exit. Zero pledged shares throughout the history is a clean signal.

Insider activity

Insider transaction dataset is empty — no reportable insider purchases or sales filed. Promoter holding held flat at 41.37% for four straight quarters (Dec 2024 to Jun 2025), then 41.34% since. The message is "we raised QIP to grow, not to cash out."

Dilution and capital allocation

The cleaner takeaway: Chirag Parekh did not chase glossy M&A with QIP funds. The UK acquisitions predated the QIP and are the one blemish — three consolidated UK subsidiaries turned loss-making in FY24/FY25 and required management time. United Granite is the bigger swing: acquired October 2023, integration drags admitted in Q3 FY24 and Q4 FY24 calls, narrative now (Q2 FY26) is a turnaround. Investors are effectively being asked to trust the founder's judgment here — there is no independent acquisition committee disclosed.

Related-party behavior

The Corporate Governance Report states all RPTs were "in the ordinary course of business and on an arm's length basis" and "not materially significant." There is no explicit disclosure of a promoter-family member on payroll in the data available to this analyst. Audit Committee is 100% independent-member controlled on RPT votes (by SEBI design). No loans/advances to firms-where-directors-are-interested reported for FY25.

Skin-in-the-game score

Score: 6.5/10. Scoring rationale: (+) founder-promoter MD with Rs. ~780 Cr of personal stock at risk, (+) zero pledge, (+) 23+ year continuous control, (+) QIP deployed for operating capacity not self-enrichment. (−) No independent directors own any shares — no insider alignment beyond the family, (−) MD comp absorbed 14% of standalone PAT FY25, (−) promoter stake has declined ~270 bps in 4 years (dilution, not selling, but still), (−) family-dominant governance means challenge is structurally weak. Net: more aligned than the average BSE SmallCap but short of best-in-class.

Board Quality

Independence ratio: 75% (6 of 8) — high for an Indian promoter-led small-cap. Attendance: strong — every director attended at least 7 of 8 board meetings; Parekh, Sharma, Ambani and Godiawala attended all 8. Every director attended the last AGM.

Expertise gaps. The board has finance (three directors), design/R&D (one), legal (one), and sustainability (one). What's missing for a company executing a US export + UK fabrication + domestic retail strategy: no director with US-market or building-products distribution experience; no director with deep M&A/integration experience (Godiawala has insolvency, not corporate M&A); no professional CEO-class operator independent of the promoter family. Katja Larsen's "sustainability" expertise covers ESG check-the-box but she serves on zero other listed boards and has no public corporate track record disclosed.

Committee quality. Audit Committee is chaired by Prabhakar Dalal (independent, finance), Nomination & Remuneration likewise. Risk Management Committee is chaired by Chirag Parekh himself — a structural weakness, as the CEO is marking his own homework on risk. CSR is also MD-chaired, which is acceptable.

Promise-vs-delivery record from transcripts. Across 10 consecutive earnings calls, the Chairman consistently anchored guidance and has a mixed delivery record on the two commitments that matter most: the Rs. 1,000 Cr FY25 revenue target, and the 18–20% EBITDA margin band.

The pattern is: Chirag Parekh over-promised in FY24, course-corrected verbally through FY25 without formally retracting, and has guided FY26 more conservatively (18–20% margin band, which he is now hitting). The IKEA global RFQ win is the first genuinely quantified external validation — if it plays out at 3x the previous share and capacity utilization holds at 85–90%, the FY27 numbers will vindicate the capex. If capacity can't be built fast enough (management has already flagged mold bottlenecks), the narrative softens again.

The Verdict

Grade: B. Reasonable for an Indian promoter-led exporter — not best-in-class.

Strongest positives.

• Founder with Rs. ~780 Cr personal stake, zero pledge, and a 38-year operating history. The most important alignment question — does the person running this company personally care about the stock? — answers a clear yes.
• 75% independent board with visible refresh (three new IDs in FY24–FY25), real attendance (≥7/8 for all), and committee leadership concentrated with a finance-credentialed Lead Independent Director.
• Capital allocation has been operational, not promotional: QIP deployed on capacity tied to a secured IKEA RFQ, no related-party self-dealing disclosed, zero loans/advances to director-connected firms, ESOP pool capped at 3 lakh options.

Real concerns.

• MD compensation at ~14% of standalone PAT (required a LODR Schedule V special resolution) is toward the aggressive end, and base-plus-perks of Rs. 7.03 Cr is fixed regardless of performance.
• The Risk Management Committee is chaired by the MD himself — the person most exposed to a negative risk finding.
• The FY25 NRC-composition LODR violation is a small but telling compliance miss for a company that markets its governance.
• Bench depth is thin: if something happened to Chirag Parekh, the only executive on the board is the CFO. No COO, no President, no declared succession plan in the Corporate Governance Report.
• Senior-most Independent Director (Sonal Ambani) exits March 31, 2026; who replaces her determines whether the board gets stronger or weaker.

What would cause an upgrade to A–. A formally disclosed succession plan naming an internal #2 beyond the CFO; moving Risk Committee chair to an independent director; a clean FY26 without further SEBI LODR penalties; IKEA ramp delivering the Rs. 1,000 Cr+ milestone that has been promised since FY24.

What would cause a downgrade to C+. Another LODR penalty or related-party disclosure; MD compensation rising again while PAT growth stalls; or an impairment on the UK subsidiaries / United Granite that signals the M&A decisions were not disciplined.

Claude View

The Full Story

Carysil is a thirty-nine-year-old Gujarat-based quartz-sink manufacturer that, in the space of five years, tried to become a global kitchen-and-bath brand by layering four bolt-on acquisitions onto a once-concentrated export OEM model. The COVID-era boom (FY2021–FY2022) flattered margins and management set ambitious multi-year revenue targets; the subsequent destocking crunch (FY2023–FY2024) exposed how thin the India B2C story really was and how little the acquired subsidiaries (Tap Warehouse, Carysil Surfaces UK, United Granite US) added while they absorbed debt, integration costs and write-downs. The current chapter (FY2025–FY2026 YTD) is a genuine reset: the name change from Acrysil to Carysil completed in 2022 is now matched by a real product-and-brand platform (IKEA non-US RFQ, Karran/Lowe's ramp, OEM wins with Kohler/Hafele/Smeg), margins have climbed back to ~20%, and debt is falling. Credibility has improved — but only after a two-year stretch where several promises slipped by a full year.

1. The Narrative Arc

The story has four distinct chapters. FY2021–22 (the COVID tailwind): Home renovation demand exploded, quartz-sink volumes jumped 44%, EBITDA margins hit an all-time high of 23.5%, and management — emboldened by a successful NSE listing and the death of founder Ashwin Parekh — promised Rs. 500 Cr turnover (hit in FY2022), then Rs. 1,000 Cr. FY2023 (the pivot year): The company renamed itself Acrysil → Carysil to build a consumer brand, doubled quartz capacity to 1 million sinks, but margins compressed from 22% to 18% as Western retailers began destocking. FY2024 (the hangover): Volumes recovered but profitability stalled — United Granite was bolted on at a 7–11% EBITDA margin (vs. consolidated 19%), Red Sea freight costs spiked, and the Rs. 1,000 Cr target was quietly pushed out. FY2025–26 (the reset): A Rs. 125 Cr QIP recapitalized the balance sheet, a run of marquee wins (Karran–Lowe's 150K sinks across 1,800 stores, IKEA non-US RFQ tripling wallet share from ~25% to ~75%) rebuilt capacity utilization from 65% to ~88%, and the US tariff shock in H1 FY2026 was navigated via discounts that were later rolled back after the India-US 18% tariff deal in early 2026.

2. What Management Emphasized — and Then Stopped Emphasizing

Three patterns stand out. First, what was loudest is now quiet. The "Atmanirbhar" (self-reliance) theme that dominated FY2021 and FY2022 chairman letters has essentially disappeared from calls since FY2024 — the narrative has flipped from "India manufacturing hub" to "tariff-arbitrage global supplier," which is a cleaner value proposition but admits less national-mission branding. Sternhagen, the luxury bathroom brand positioned as a major growth lever in FY2021 with Sussanne Khan and Farah Ali Khan endorsements, was quietly walked back — the Q4 FY2024 call admitted Sternhagen "has been struggling for a while, especially since we're not focusing on this," a rare piece of candor. Second, what emerged loudly is entirely new. OEM deals with big brands (Kohler India, Hafele, Smeg Italy, IKEA global), in-house appliance and faucet manufacturing, and tariff/trade-deal commentary became dominant themes only from FY2025 onward. Third, the acquisitions migrated from "synergy story" to "cost center." The UK subsidiary Tap Warehouse was celebrated in FY2022 as a GBP 11 Million acquisition unlocking "scale, cross-selling and brand building"; by FY2025 it was described as "doing consistent performance" — a euphemism. United Granite was introduced in FY2024 as a margin-expansion opportunity (7–11% to 15%+) but needed two full years to hit breakeven.

3. Risk Evolution

The risk narrative has evolved from physical-world risks (pandemic, freight, raw materials) to policy and structural-execution risks. Destocking was the dominant risk of FY2023–early FY2024 and has fully dissipated — inventory at US and UK retailers normalized by Q3 FY2024, and volumes recovered. Red Sea freight was the defining risk of FY2024 — freight cost rose from 6.5% to 9.3% of revenue, costing Rs. 2.1 Cr in Q3 FY2025 alone — and has also receded. Tariff risk is the new dominant risk: in Q1 FY2026 the US tariff on Indian goods hit 25% (escalating to 50% in mid-2025), forcing Carysil to offer 15–20% discounts to US customers to preserve volume; this resolved in Q3 FY2026 when India-US agreed to an 18% bilateral tariff, letting the company roll back discounts "with immediate effect." Customer concentration is the quietly-growing risk — the CMD disclosed in Q3 FY2026 that "US, IKEA and all put together would be about more than 60% of the business" in quartz, up materially from FY2021 when IKEA was barely a year old. Domestic B2C execution remains elevated because each year's growth target gets repeated but never truly delivered.

4. How They Handled Bad News

The pattern is that Carysil handles operational shocks well (freight, tariffs, raw material) — with specific numbers, honest framing, and defined recovery paths — but handles strategic missteps slowly (subsidiary underperformance, domestic B2C slippage, brand failures). Sternhagen is the clearest example: after being positioned in FY2021 as a second growth pillar with celebrity endorsers, it disappeared from commentary without a formal retraction until an offhand admission two years later. United Granite's 18-month trough was similarly narrated through euphemisms ("integration effects", "initial period of learning") before Q3 FY2025's direct acknowledgment. The positive read is that the tariff response in FY2026 — clearly communicated, numerically specific, and delivered alongside 27% quartz volume growth — suggests management learned from the earlier episodes.

5. Guidance Track Record

Credibility score: 6.5/10 — improving. The record is not pristine: the two biggest headline promises of the COVID era (Rs. 1,000 Cr consolidated by FY2025 and the domestic Rs. 500 Cr "medium-term" target) both slipped, and two key subsidiary-level promises (domestic Rs. 200 Cr, United Granite margin ramp) missed by material magnitudes. But recent execution is clean: margin guidance 18–20% has held through Red Sea freight, a US tariff shock and an integration, the QIP was deployed as committed, IKEA and Karran wins were delivered on schedule, and the US subsidiary turnaround happened in the predicted window. The score trajectory is up — the last eight quarters of guidance has a materially better hit rate than the prior eight.

6. What the Story Is Now

The Carysil story, as of Q3 FY2026, is the cleanest it has been in five years. The quartz-sink core business is firing on all cylinders — volumes up 27% Y-o-Y despite a 50% US tariff, capacity utilization at 88%, IKEA's non-US RFQ tripling wallet share, and Lowe's rolling Carysil sinks into 1,800 US stores through Karran. Stainless steel has found a genuine second-wind with OEM wins at Kohler India, Hafele and Smeg Italy, plus supplies to IKEA. Margins are back to ~20% even after accommodating discount-led tariff support. Debt is falling organically (Rs. 300 Cr in March 2024 to Rs. 228 Cr in December 2025) despite the growth capex. The QIP-funded platform — in-house appliance and faucet manufacturing (50K to 100K units each), glass processing, PVD lines, new experience centres — is positioning the company as an integrated kitchen-and-bath ecosystem rather than just a sink OEM.

What has been de-risked since FY2023:

Customer concentration has broadened — IKEA went from partial to deep, Karran became anchor with Lowe's, OEM base broadened to 4–5 global brands. Balance sheet is healthier with QIP Rs. 125 Cr plus falling debt plus ~20% margins. Western demand cycle destocking is fully over and volumes are at all-time highs. The US subsidiary finally turned PAT-positive in Q2 FY2026. Trade policy overhang is resolved: India-US 18% deal (vs 50% prior), UK FTA, EU FTA negotiations underway. Raw material volatility is benign again — MMA prices now $1.50/kg vs $2.52 peak, freight normalized.

What still looks stretched:

The domestic Rs. 500 Cr target is a 5-year vision document that has been "5 years away" for at least two years. The India business is real (~Rs. 170 Cr) and growing 18–30% in recent quarters, but the multi-brand platform (Carysil + Sternhagen + TekCarysil + appliances + faucets) is operationally complex and the track record of India B2C delivery has been the weakest part of the story.

Key-person risk on Chirag Parekh — succession is not publicly addressed. The CMD is the entire face, strategy and execution voice of the company.

Surfaces business (United Granite + Carysil Surfaces UK) is flat-to-soft and has been described by management as "challenging" in UK; scaling it into India is a stated plan but not yet proven.

Faucets and appliances in-house manufacturing is still sub-scale (50K-100K units) vs the ambition — execution risk remains.

What the reader should believe vs. discount:

The current chapter reads as a company that tripped badly in FY2023–FY2024 (acquisitions layered during a demand peak, narrative outrunning delivery), then used the QIP and the macro reset (tariff repositioning, China+1) to reload. The next chapter's honesty test is the India plan unveiled in April 2026 — if it lands with specific targets tied to specific capacity and channels (rather than another aspirational Rs. 500 Cr), credibility moves from 6.5 toward 8. If it is another top-down number, the ceiling stays where it is.

Claude View

What's Next

Four dated events over the next eight weeks decide whether the FY26 recovery narrative is a genuine re-rating or a cost-pull head-fake. The May 2026 Q4 print is the hinge — not because the top-line is in doubt (9M FY26 already beats all of FY25) but because three line items on that single release will tell you whether the thesis is volume-led and working-capital-healed, or merely resin-cost-pulled with inventory still stuck at 290 days. Before Q4, the April 25 Carysil 2.0 expo will either retire the credibility overhang on the domestic ₹500 Cr target or extend it by another year.

The earnings catalyst the market is already positioning for (May 15, 2026 window) is binary on working capital, not on revenue. Quant's base case puts FY27 EPS at ~₹46 on op margin of 19% and gradual US recovery — that is how the stock holds at ₹906 today; the bull case to ₹1,500+ only triggers if inventory days start unwinding from 290 and quartz utilisation confirms 80%+ on the call. The April 25 expo is softer but more narratively loaded — Historian and web research agree the ₹500 Cr domestic target has slipped at least 2 years and is now reframed by MNCL as "₹5bn over 3–4 years." If the vision document ships with concrete capacity and channel milestones (rather than another top-down number), credibility moves from 6.5 toward 8.

For / Against / My View

For

The margin recovery is printed, not promised. Three consecutive quarters at 19% operating margin with net income roughly doubling YoY. 9M FY26 NI of ₹71 Cr already clears full-year FY25 (₹64 Cr), and Q3 FY26 PAT of ₹21 Cr was +68.6% YoY. The re-rating is happening in real numbers, not forward guidance — the rare case where the street's +46% FY26 PAT forecast looks conservative against quarterly trajectory.

The sole-source relationships are now contract-bound, not aspirational. Karran's December 2024 $68M / ₹550 Cr 5-year renewal is additive to the March 2025 150,000-units/year dedicated-capacity deal that put Carysil sinks into 1,800 Lowe's US stores (supply live since May 2025). IKEA's non-US global RFQ tripled Carysil's wallet share from ~25% to ~75%, with ₹36 Cr of mould capex already committed. This is the first time in five years the bookings side of the bet is validated by external procurement, not internal revenue targets.

Working-capital latency is the cheap optionality. Inventory days at 290 have ~₹195 Cr of cash trapped vs. FY23 norms. If Q4 FY26 inventory days revert toward 200 without a revenue decline, ROCE mechanically recovers 300–400bps and FCF conversion normalises — Quant's 3-year-avg FCF path moves the P/FCF multiple from 198x to ~35x without needing a single new order. The unlock reports in 28 days.

The balance sheet was recapitalised at exactly the right moment. Historian frames the July 2024 ₹125 Cr QIP as the single most important inflection — Sherlock confirms deployment into capacity tied to a secured IKEA RFQ, not opportunistic M&A. Debt has fallen from ₹300 Cr (Mar 2024) to ₹228 Cr (Dec 2025), D/E is 0.42x, promoter dilution was from fresh issue rather than cash-out, and zero pledge runs through the entire history.

EV/EBITDA at 14x is the single clean peer-relative dislocation. Carysil's +19% FY25 revenue growth is roughly 3x what Cera or Kajaria are printing, yet EV/EBITDA sits at a clear discount to both (Cera 20.4x, Kajaria 27.1x). If 9M FY26 margins hold through Q4, institutional screeners catch up even before the utilisation story plays out.

Against

The 11-year record says this is a capex-cycle exporter, not a compounder. Quant's hardest number: ₹611 Cr of cumulative capex (FY21–FY25) produced ₹540 Cr of incremental revenue and essentially zero incremental net income — PAT flatlined at ₹53–65 Cr since FY22 even as revenue doubled. At 15.4% ROCE vs. Cera's 22.4%, paying a Cera-equivalent 28.5x P/E is paying for mean reversion that has not started and has no operational trigger date before FY27.

FCF conversion is the thesis-breaker, not a footnote. Over FY22–FY25 cumulative FCF was negative ₹29 Cr while reported PAT totalled ~₹240 Cr — roughly zero cash earnings for four years. If Q4 FY26 inventory days stay above 260 and the working-capital bloat proves structural (stale SKUs, tariff-era finished stock, permanently higher retailer stocking), the entire "margin recovery" narrative becomes an accounting artifact — Warren's 290-day inventory flag is the specific mechanism.

Customer concentration has widened, and the 18% tariff deal is fragile. The CMD disclosed in Q3 FY26 that US + IKEA together exceed 60% of quartz revenue, with Karran alone running ~20–25% of quartz volume as sole-source. The April 15, 2026 Reuters piece noted the US-India 18% framework "has been clouded by a Supreme Court ruling" — the deal was announced via social media, is not formally ratified, and any step back toward 25%+ forces Carysil to re-impose 15–20% customer-support discounts exactly as it did in H1 FY26.

Credibility is 6.5/10 because the India pivot keeps slipping. Historian logged 6 of 12 tracked promises as hits; the 4 big misses include the ₹1,000 Cr FY25 target missed by ~18%, the domestic ₹500 Cr promise quietly reframed from "medium-term" to a 5-year vision doc, Sternhagen walked back without a formal mea-culpa, and United Granite ramp 6 quarters late. The April 25, 2026 expo is the third iteration of the same top-down India playbook — believing the new number requires discounting the last two.

Governance is B with a live compliance scar. Sherlock: FY25 NSE/BSE monetary penalty for NRC composition (a basic LODR 19(1) failure), MD pay at ~14% of standalone PAT (tripped LODR Schedule V), the MD chairs his own Risk Committee, succession is publicly unaddressed, and Sonal Ambani's exit on March 31, 2026 is filed with no successor named. None of these is fatal, but they compound the "trust the founder" requirement at precisely the valuation where trust is most expensive.

My View

Close call, slight edge to the bears — but only because the price has already moved. At ₹906 the stock has doubled off the ₹582 tariff-scare low, which means you are no longer paid for the asymmetry that existed six months ago. The real tension across the four specialists is that Warren and Historian both see a genuinely cleaner operating story than the last five years (margins printed, capacity utilised, IKEA and Karran contracted), while Quant's multi-year capital-efficiency ledger and Sherlock's credibility read both argue that the business earns 15% ROCE on a Cera-equivalent multiple — expensive unless inventory unlocks and India accelerates simultaneously. I would not short this and I would not chase it here; I would wait out the April 25 expo and the May 15 Q4 print, specifically watching for inventory days to close below 250 and for management to tie the April India plan to concrete capacity commitments rather than another ₹500 Cr aspiration. The single data point that would flip the view bullish is an inventory-days print at or below 230 on the Q4 FY26 balance sheet — because that is the one number on which Warren's operational thesis, Quant's valuation math, and the base-case P/FCF all converge, and it reports before any of the harder narrative tests have to be passed.

Claude View

Web Research

The single most valuable thing the web adds to this file is timestamped confirmation of the three pivot events that happened after the FY25 annual report closed: the India–US 18% tariff deal on Feb 2, 2026 that collapsed the Q1–Q2 FY26 discount regime, the Karran/Lowe's 150,000-unit/year "major US retail chain" supply order that began shipping May 2025, and Dr. Sonal Ambani's second-term exit on Mar 31, 2026 — a live board-refresh event the filings don't cover yet. The web also exposes what the filings hide: the real global competitor is privately-held Schock of Germany (~21% global granite-sink share, ~2 million units/year) — not any listed Indian peer — and street analysts have quietly raised the domestic target from ₹500 Cr to "₹5 Bn over 3–4 years", a softening of Chirag Parekh's original "medium-term" commitment that is material to the re-rating thesis.

The Bottom Line from the Web

The web broadly confirms management's recovery narrative — MNCL target ₹1,190, Anand Rathi 28% upside, Trendlyne 4-analyst consensus ₹1,206 with 46% FY26 profit-growth forecast, 19–20% margin run-rate validated by Q3 FY26 print — but quietly contradicts the timeline on the domestic India story and elevates tariff policy from "resolved" to "watch-list" (the Feb 2026 deal was announced via Trump tweet with no formal ratification; a Supreme Court ruling in April 2026 has clouded the 18% framework). Positioning against private-held Schock shows Carysil is the #2 global quartz-sink maker, not the #4 claimed on its own website.

What Matters Most

1. India–US 18% tariff deal (Feb 2, 2026) is live — but fragile

The United States cut reciprocal tariffs on Indian goods from 50% to 18% effective Feb 2, 2026, specifically covering "plastic and rubber, organic chemicals, home décor… and certain machinery" — the HS codes that cover quartz composite sinks. This is what let Carysil roll back its 15–20% customer-support discounts in Q3 FY26 and drove the margin snap-back to 19.4%. Reuters, The White House joint statement, Cleartax, Morgan Lewis, and Lexology all confirmed the deal. A Reuters piece on April 15, 2026 noted the framework "has been clouded by [a] Supreme Court ruling" and talks continue — meaning the 18% is not yet formally ratified and could revert.

Sources: whitehouse.gov/briefings-statements/2026/02/united-states-india-joint-statement/, reuters.com/world/india/india-us-trade-deal-slashes-tariffs-lifts-exports-markets-2026-02-03, reuters.com/world/india/indias-trade-deficit-2098-billion-march-2026-04-15, cleartax.in/s/us-tariff-on-india, morganlewis.com/pubs/2026/02/us-india-trade-deal-cuts-tariffs-eases-tensions

2. Karran/Lowe's contract is bigger than filings suggest — $68M over 5 yrs PLUS 150k units/yr NEW

Two distinct Karran data points that the specialist filings read as one: (a) a renewed ~$68 million / ₹550 Cr, 5-year contract disclosed Dec 13, 2024 (MarketScreener, Dec 13 2024); and (b) a brand-new 150,000-units-per-annum dedicated-capacity arrangement announced March 12, 2025 to supply "a major U.S. home retail chain" via Karran — widely reported to be Lowe's (1,800 stores). These are additive, not overlapping — the March 2025 announcement specifically says "new major U.S. home retail chain." Supply commenced May 2025. Street coverage from Business Upturn, Business Standard and CNBC TV18 (which noted a +5% single-day stock move on the news) treats this as the single biggest order win in company history.

Sources: businessupturn.com/business/corporates/carysil-secures-major-us-deal-signs-agreement-with-karran-inc-for-quartz-sink-supply, business-standard.com/markets/capital-market-news/carysil-rises-after-bagging-supply-contract-quartz-kitchen-sinks-from-major-usa-customer-125031200388_1.html, cnbctv18.com/market/carysil-gains-5-percent-on-deal-to-supply-quartz-kitchen-sinks-to-major-us-retail-chain-19572461.htm, in.marketscreener.com/quote/stock/CARYSIL-LIMITED-14788517/news/Carysil-Limited-Renews-Contract-with-Karran-Inc-USA-for-Supply-of-Quartz-Kitchen-Sink-for-Value-o-43380242/

3. Customer concentration is LARGER than filings admit — "US + IKEA = 60%+ of quartz"

Answering Warren's top-priority question: Q3 FY26 call disclosure (sourced via Livemint/Multibagg/MNCL reports) contains a CMD admission that US customers plus IKEA together account for more than 60% of quartz-sink revenue. Management has not broken out Karran-only concentration, but given 150k units dedicated to one Lowe's SKU against roughly 700k–800k expected quartz volumes in FY26, Karran alone likely runs ~20–25% of quartz volume. This is materially above the "under 20% top-customer" disclosure the market has been assuming from older annual reports. Cashcows Substack (Apr 2025) also lists "high dependency on top 5 clients" as its lead risk.

Sources: livemint.com/market/stock-market-news/carysil-quartz-sink-market-donald-trump-tariffs-stock-performance-analysis-revenue-profit-sensex-nifty-11757915235663.html, multibagg.ai/deep-dive/blogs/91320-carysil-q3-fy26-momentum, cashcows.substack.com/p/carysil-lowest-cost-global-contract

4. The real competitor is Schock (Germany, ~2M units/yr, 21% global share) — not any listed Indian peer

Warren's specialist question asked for the Schock benchmark. Findings: Schock holds ~21% of the global granite/quartz kitchen-sink market (IK Partners exit documentation), produces ~2 million units/yr (Schock PDF catalogue on ArchiExpo), operates from one plant in Regen, Bavaria, has 90+ patents, and serves 70+ countries. Schock invented the category in 1979. Carysil's entire commercial moat rests on being Schock's ex-technology partner (original 1987 collaboration per moneycontrol company history) operating at India labour and power costs — Girish's Notes and Cashcows Substack both triangulate Carysil at "20–25% cheaper pre-European energy crisis, 35–40% cheaper post."

The global quartz-sink market is small: Research and Markets/Skyquest peg it at USD 297M–350M (FY24) growing to USD 440M–710M by 2032–2033. Carysil's 1M-unit capacity at ~$40–50 ASP = ~$40–50M of that market, giving it ~12–15% global share — i.e., Carysil is the clear #2 globally behind Schock, not "fourth-largest" as its own website historically claimed.

Sources: ikpartners.com/investments/schock/, pdf.archiexpo.com/pdf/schock/schock/50480-293196.html, schock.de/int_en, researchandmarkets.com/reports/5766571/quartz-market-report, skyquestt.com/report/quartz-sink-market, girishnotes.substack.com/p/carysil-ltd, cashcows.substack.com/p/carysil-lowest-cost-global-contract

5. Analyst targets point UP — consensus ₹1,206–₹1,265 — but the recent downgrade is a warning flare

MNCL: BUY ₹1,190 (Feb 11, 2026), rolled to FY28E, sees 18% revenue CAGR FY25–FY28. Anand Rathi: BUY, 28% upside (Oct 24, 2025). Trendlyne 4-analyst consensus: ₹1,206 price target, +14.7% revenue forecast, +46% profit forecast for FY26. Alpha Spread: Wall Street average ₹1,229.78 (range ₹1,086.76–₹1,375.50). Morningstar: "fairly valued." But MarketsMOJO downgraded Carysil from Hold to Sell on Mar 23, 2026 citing bearish technicals — and then to Hold on Apr 1, 2026 "on improved fundamentals" (EV/CE 3.1x = "reasonable"). The split tape explains why the stock sits at ₹906 — mid-way between bull/bear targets.

Sources: mnclgroup.com/carysil-ltd-crafting-the-future-of-modern-kitchens-company-update, business-standard.com/markets/news/is-carysil-your-next-growth-stock-anand-rathi-says-buy-28-upside-eyed-125102400476_1.html, trendlyne.com/equity/consensus-estimates/3001/CARYSIL/carysil-ltd/, alphaspread.com/security/nse/carysil/analyst-estimates, marketsmojo.com/news/stock-recommendation/carysil-ltd-downgraded-to-sell-amid-bearish-technicals-despite-strong-financials-3909310

6. India target was quietly walked down from ₹500 Cr to "₹5 Bn over 3–4 years"

MNCL's Feb 11, 2026 research note describes management's India ambition as building "a Rs 5bn India business over the next 3–4 years." This is the same ₹500 Cr number, but the reframing is telling: the original FY24 chairman's letter called it "medium-term"; Q1 FY25 CMD said "if things go well"; Q3 FY26 transcript now reads it as a 5-year vision document to be unveiled at the April 25, 2026 Carysil 2.0 expo. Net: the number is intact but the timeline has slipped roughly 2 years in the retelling without any formal retraction. This is exactly the pattern Historian (story-claude) identified in the guidance-track record.

Sources: mnclgroup.com/carysil-ltd-crafting-the-future-of-modern-kitchens-company-update, scanx.trade/stock-market-news/companies/carysil-limited-announces-analyst-interaction-at-carysil-2-0-experience-expo-on-april-25-2026/37259235, finance.yahoo.com/news/carysil-ltd-bom-524091-q1-090031808.html

7. Board refresh event: Ambani exit on Mar 31, 2026 is already filed — successor not yet disclosed

Carysil Limited officially announced (Apr 1, 2026) the completion of Dr. Sonal Ambani's second and final consecutive term as Independent Director on Mar 31, 2026. Sherlock flagged this as the board-quality inflection point. As of the research cut-off, Carysil has not publicly named a successor. The company's Q4 FY26 quarterly compliance certificate (April 2026 filing) references the transition but does not name a replacement. This is a board-quality question to revisit post the April 25, 2026 investor event.

Sources: scanx.trade/stock-market-news/companies/carysil-limited-announces-completion-of-dr-sonal-ambani-s-second-term-as-independent-director/36535412, scanx.trade/stock-market-news/companies/carysil-limited-submits-quarterly-compliance-certificate-for-q4-fy26/37194254

8. UK market (39.6% of revenue) expected to stabilize in 2026 — but Kingfisher/Wickes warning signs

Warren asked for UK housing-renovation data. Mordor Intelligence: UK kitchen furniture market USD 2.5B (2025) → USD 2.61B (2026) → USD 3.21B (2031), 4.23% CAGR. Mintel: 55% of UK consumers refreshing bathrooms in 2025 (vs 52% in 2024). kbbreview kitchen report: "by 2026 we expect the picture to start improving." GlobalData: UK kitchen furniture +£172M (2024–2029). But Retail Gazette (Mar 2026) describes Kingfisher (B&Q owner) as facing a "make-or-break moment" and Wickes CEO calling trading "challenging." The UK is recovering but the macro remains fragile for big-ticket renovation.

Sources: mordorintelligence.com/industry-reports/united-kingdom-kitchen-furniture-market, store.mintel.com/report/uk-kitchens-and-kitchen-furniture-market-report, kbbreview.com/77680/indepth/the-2025-kitchen-market-report/, retailgazette.co.uk/blog/2026/03/kingfisher-faces-make-or-break-moment-as-home-improvement-market-wobbles/, insightdiy.co.uk/news/wickes-further-growth-in-all-business-areas-market-share-increased/15913.htm

9. Resin/MMA input costs stable through Q4 2025 — supporting the margin story

Quant asked if the Q2 FY26 margin pop is cost-pull or volume-pull. Finding: ChemAnalyst reports "Petroleum Resin Production Cost Trend remained stable through Q4 2025 as feedstock costs for C5 and C9 hydrocarbon fractions experienced minimal volatility," supporting management's "cheaper imported quartz resin" commentary. Naphtha IMARC: Sep–Dec 2025 upward movement only +0.1%. Caveat: April 2026 PlasticsToday ("The 2026 Insider's Guide") flags "the most broadly synchronized upward pressure across resin categories that many buyers have seen in several years" starting April 2026 — a risk if it accelerates.

Sources: chemanalyst.com/Pricing-data/petroleum-resins-1128, imarcgroup.com/naphtha-pricing-report, plasticstoday.com/resin-pricing/the-2026-insider-s-guide-to-resin-pricing

10. Sternhagen is being quietly re-launched — NOT retired

Historian flagged Sternhagen as the "dropped theme." The web shows a new flagship experience centre opened in Delhi (late 2025) and a Gurugram experience centre opened by Diana Penty on Nov 26, 2025. Indian Retailer coverage (Apr 2026): "Sternhagen Bets Big on India with its First Flagship Centre in Delhi." This is the first full-fledged Sternhagen-branded experience centre, separate from prior in-store displays. The brand was also featured in a Charcoal Project / Sussanne Khan collaboration (Mar 2025). So the walk-back observed in transcripts is being followed by a quiet re-investment cycle — worth tracking whether it actually generates revenue this time.

Sources: indianretailer.com/interview/retail-people/profiles/sternhagen-bets-big-india-its-first-flagship-centre-delhi, passionateinmarketing.com/sternhagen-opens-its-new-experience-centre-in-gurugram-a-new-landmark-in-bathroom-luxury/, elledecor.in/sternhagen-and-carysil-join-forces-with-sussanne-khan-the-charcoal-project-for-a-refined-bathroom-and-kitchen-collection/

Recent News Timeline

What the Specialists Asked

Analyst Sentiment Snapshot

Industry Context

Global quartz-sink market — smaller and more concentrated than it looks

The quartz-sink category is a small slice of the total kitchen-sink market (~$3.9Bn in FY25) but the one Carysil plays in. Two leaders — Schock (Germany, ~21%) and Carysil (India, ~13–15%) — account for roughly 35% of global volume. Blanco, Franke, Elkay and Franz Viegener round out the top of the list.

UK kitchen furniture market — stabilizing in 2026

UK at 4.23% CAGR through 2031 is a mid-single-digit tailwind for Carysil's largest single geography (39.6% of revenue). But Kingfisher/B&Q and Wickes both flagging "challenging trading" in Mar–Apr 2026 suggests the recovery is tentative.

India–US trade: the regime change Carysil pivots around

The 50% tariff regime lasted ~5 months and forced Carysil into 15–20% customer-support discounts that management rolled back after Feb 2. This whole tariff arc is visible in Q3 FY26 margin recovery — which is also why the April 15 Reuters "Supreme Court cloud" headline matters more than it looks.

Sources & Methodology